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Abstract
Ankle osteoarthritis (AOA) is a severe pathology, mostly affecting a post-traumatic young population. Arthroscopic
debridement, arthrodiastasis, osteotomy are the current joint sparing procedures, but, in the available studies,
controversial results were achieved, with better outcomes in case of limited degeneration. Only osteotomy in case
of malalignment is universally accepted as a joint sparing procedure in case of partial AOA. Recently, the biological
mechanism of osteoarthritis has been intensively studied: it is a whole joint pathology, affecting cartilage, bone and
synovial membrane. In particular, the first stage is characterized by a reversible catabolic activity with a state of
chondropenia. Thus, biological procedures for early AOA were proposed in order to delay or to avoid end stage
procedures. Mesenchymal stem cells (MSCs) may be a good solution to prevent or reverse degeneration, due to
their immunomodulatory features (able to control the catabolic joint environment) and their regenerative
osteochondral capabilities (able to treat the chondral defects). In fact, MSCs may regulate the cytokine cascade and
the metalloproteinases release, restoring the osteochondral tissue as well. After interesting reports of mesenchymal
stem cells seeded on scaffold and applied to cartilage defects in non-degenerated joints, bone marrow derived
cells transplantation appears to be a promising technique in order to control the degenerative pathway and restore
the osteochondral defects.
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Introduction
Ankle osteoarthritis (AOA) is a severe disabling path-
ology affecting 1 % of the adult population (Barg et al.
2013; Valderrabano et al. 2009). Primary AOA is usually
rare, whereas post-traumatic AOA largely predominates:
malleolar fractures and ligament injuries are the most
frequent etiologies (Barg et al. 2013; Valderrabano et al.
2009). After acute injuries, there is a conspicuous risk of
degenerative progression, ranging from 40 % to 60–70 %
in case of complex fractures (Lübbeke et al. 2012). When
AOA becomes established, conservative approach could
be adopted, but in many cases surgical treatment is
needed (Bloch et al. 2015; DiDomenico & Gatalyak
2012). Arthrodesis is still considered the gold standard
in case of surgical treatment of severe AOA, but foot
joints osteoarthritis may be faced at long follow-up
(Bloch et al. 2015; Jordan et al. 2014). Recently, total
ankle replacement has gained more and more success,
but serious post-operative complications and risks of
multiple revision procedures, especially in young pa-
tients, are the main disadvantages of the procedure
(Bloch et al. 2015; Jordan et al. 2014). Considering the
drawbacks of the previous end-stage procedures and the
average young age of the patients affected with post
traumatic AOA, joint sparing procedures should be
considered, mostly in case of precocious degeneration
(Bloch et al. 2015; Lübbeke et al. 2012; Madry et al.
2012; Valderrabano et al. 2009). In early degeneration,
the whole joint is affected by a mild deteriorating pro-
gression, with still a good, reversible balance between
anabolic and catabolic processes (Gomoll et al. 2012;
Madry et al. 2012). Thus, joint sparing surgical proce-
dures may be desirable, with the aim to delay the degen-
erative progression, postponing or even obviating the
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Nowadays, three surgical procedures with joint sparing
aim are currently performed for early AOA: arthroscopic
debridement, arthrodiatasis, osteotomy (Zgonis et al.
2006; Weatherall et al 2013).
Arthroscopic debridement
Ankle arthroscopy in AOA was reported to be useful in
alleviating symptomatology, but ineffective at treating the
pathology (Hassouna et al. 2007). In the work by Tol et al,
57 patients with ankle anterior impingement syndrome
were arthroscopically treated with debridement (Tol et al.
2001). Patients with no radiographic signs of AOA had
excellent outcomes at mid-term follow-up (5–8 years).
Patients with AOA had lower outcomes, with a significant
relationship with pre-operative radiographic AOA classifi-
cation: nevertheless, the Authors observed a noticeable
clinical improvement. Parma et al described similar out-
comes after arthroscopic debridement in patients with
anterior impingment (Parma et al. 2014). In a case series
of 80 patients analyzed at long-term follow-up (10 years),
chondral lesions, advanced age and previous trauma were
negative prognostic factors. Patients with narrowing of the
joint space had lower outcomes, being the Van Dijk’s clas-
sification for AOA predictive of worst results (Tol et al.
2001). Consequently, the Authors proposed a classifica-
tion of the anterior impingement, mixing the bony spur
localization with the cartilage status: patients with diffuse
bony impingement and concomitant narrowing of the
joint space were doomed to poor results.
Choi et al. analyzed 63 patients with mild or moderate
AOA (joint space narrowing) at medium follow-up, after
arthroscopic debridement (Choi et al. 2013). Good, but
decremental clinical results were reported. Patients with
high body mass index and intra-articular lesions, like
soft tissue impingement or chondral lesions, had lower
outcomes. Hassouna et al reported the results of arthro-
scopic debridement in 80 patients with ankle impinge-
ment or osteoarthritis at mid-term follow-up (Hassouna
et al. 2007). In case of AOA, the clinical results were
lower, with better outcomes in young patients. At 5 years,
28 % of the patients required a major surgical procedure
and 24 % of the cases underwent another arthroscopy:
most of them had AOA signs. In conclusion, ankle arth-
roscopy showed good results at medium follow-up in
patients with mild AOA: careful selection of the patients
is crucial in order to achieve a satisfying outcome. Arthros-
copy cannot be routinely recommended for AOA: other-
wise, mild and moderate AOA can be addressed to
arthroscopy, adding limited bone marrow stimulation tech-
niques (Zgonis et al. 2006; Weatherall et al 2009) (Table 1).
Arthrodiastasis
Arthrodiastasis is indicated in young patients with AOA
and a normal alignment of the ankle joint (Bloch et al.
2015; Kluesner & Wukich 2009). It consists in applying
a circular external ring fixator (usually Ilizarov) and
performing progressive distraction up to 5 mm. The key
of a successful treatment is guaranteeing weight-bearing
stability and maintaining the distraction over the time:
usually, the treatment should be prolonged to at least
3 months (DiDomenico & Gatalyak 2012; Kluesner &
Wukich 2009). Along with the distraction, other associ-
ate procedures can be added, like joint debridement, or
Achilles tendon lengthening (Bloch et al. 2015; Kluesner
& Wukich 2009; Tellisi et al. 2009).
The rationale of this procedure is based on the self-
repairing abilities of the osteochondral tissue when
unloaded (Intema et al. 2011; Lamm & Gourdine-Shaw
2009). The intermittent intra-articular hydrostatic fluid
pressure changes result in a benefit for ankle chondro-
cytes, which are particularly keen on synthesizing proteo-
glycans and collagen in response to damage (Intema et al.
2011; Lamm & Gourdine-Shaw 2009). The subchondral
bone sclerosis and the bone cysts may be reduced as well,
resulting in lower pain and better cartilage repair (Intema
et al. 2011; Lamm & Gourdine-Shaw 2009). Lamm et al
demonstrated joint space widening with fibrocartilage
formation and decreased subchondral bone thickness in
MRI after arthrodiastasis (Lamm & Gourdine-Shaw 2009)
The main complications of arthrodiastasis are related to
infections, neurovascular lesions, hardware failure and
damage to ankle ligaments (DiDomenico & Gatalyak
2012). However the main drawback of this technique is
linked to patient’s compliance (DiDomenico & Gatalyak
2012).
In the case series with the longest follow-up (7 years),
six out of 22 patients treated with ankle distraction
failed, requiring arthrodesis or resulting in Sudeck athro-
phy (Ploegmakers et al. 2005). In the majority of other
cases, good and stable clinical outcomes were achieved,
resulting in improved ankle range of motion and lower
symptomatology over the time (Ploegmakers et al. 2005).
In an open study and randomized controlled trial, ankle
distraction resulted in good outcomes, with better re-
sults over the time (Marijnissen et al. 2002). Radio-
graphic evaluation showed an increase in the joint space,
with radiographic improvement over the time. The ran-
domized controlled trial comparing ankle debridement
and joint distraction confirmed better clinical and radio-
graphic results for arthrodiastasis. However, about one
fourth of the patients did not clinically improve. Tellisi
et al described good outcomes as well, reporting only
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two failures out of 25 patients at short term follow-up
(Tellisi et al. 2009). The clinical results improved, with
good pain control and better function. In a recent work
by Nguyen et al, the clinical and radiological results at
mid-term follow-up were not so positive, with 45 % of
the patients treated with definitive end stage procedures:
Table 1 Features and results of the selected papers about arthroscopic debridement, arthrodiastasis and osteotomy in AOA
Authors Year of
publication
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differently from the previous studies, the Authors stated
that ankle function tended to decline over the time after
arthrodiastasis (Nguyen et al. 2015). A similar rate of
failure was reported in another study about ankle
distraction in AOA at long term follow-up (Marijnissen
et al. 2014). Smith et al reviewed the few studies about
ankle arthrodiastasis in AOA (Smith et al. 2012). The
report described good results, with a small amount of
failures at short term follow-up. The Authors highlighted
also the weak support by high quality trials (Smith et al.
2012). Nevertheless, the promising results make arthro-
diastasis an interesting option for AOA (Table 1).
Osteotomy
Osteotomy is indicated in case of partial joint degener-
ation, fracture malunion and axial malalignment, usually
traumatic in cause (Zgonis et al. 2006). The rationale of
osteotomy is restoring the congruity of the joint and the
normal contact areas of the articular surfaces, shifting
the forces to an healthy portion of the ankle. Usually a
malignment over 10°–15° in any cardinal plane is ad-
dressed to osteotomy (Zgonis et al. 2006). Nevertheless,
the features and flexibility of hindfoot and midfoot may
play a considerable role, compensating the malalign-
ment: usually varus deformity of the ankle is less man-
ageable due to limited eversion abilities of the subtalar
joint (DiDomenico & Gatalyak 2012). Contraindication
for realignment surgery are end stage, diffuse AOA,
infection and neurovascular disorders: the procedure is
not recommended even in smokers and older patients
with low bone quality (Barg et al. 2013). Osteotomy can
be performed around the ankle, in the fibula, or distal
tibial metaphysis or diaphyseal junction or in the calca-
neus; the deformity to be corrected can be subtalar,
supramalleolar or mixed (Myerson & Zide 2013; Zgonis
et al. 2006). Many techniques have been described:
medial opening or closing wedge osteotomy, corrective
Z-shaped osteotomy of the fibula, lateral lengthening
calcaneal osteotomy, lateral closing wedge osteotomy
(Barg et al. 2013). Frequently, the malalignment has het-
erogenic etiology, even considering ligament and tendon
dysfunction: combined approaches are required to avoid
recurrence (Myerson & Zide 2013). The rehabilitation is
quite challenging, and sport resumption is recommended
not before 4 months (Barg et al. 2013). The results after
realignment osteotomy are quite encouraging (Barg et al.
2013). Knupp reported the results of supramalleolar oste-
otomies in 94 patients after a follow-up of 3 years (Knupp
et al. 2011). Only ten ankles failed and required an end-
stage procedure (Knupp et al. 2011). Another large case
series by Colin et al reported good results in 83 patients
treated with supramalleolar osteotomies: seven cases failed
after 3,5 years (Colin et al. 2014). Colin et al recognized
the clinical sign of the sidewalk (walking on a corrective
plane) as positive predictive sign for supramalleolar oste-
otomy success (Colin et al. 2014). Recently Kim reported
the results of supramalleolar osteotomy along with arthro-
scopic microfractures in the treatment of varus AOA:
clinical outcomes after 2 years were encouraging, but
tended to worsen over the time (Kim et al. 2014). The
radiographic evaluation and the second look arthroscopy
showed degenerative progression in 42 % of the cases,
with a significative correlation with the clinical outcome
(Kim et al. 2014). Realignment procedures are effective,
restoring joint congruity and uniform loading, but a cor-
rect pre-operative plan must be performed; associate pro-
cedures on soft tissues and arthroscopic bone marrow
stimulation may improve the results (Table 1).
Future developments
Osteoarthritis (OA) is characterized by an articular tis-
sue and microenvironment alteration involving all joint
components: beyond cartilage, subchondral bone and
synovial membrane (Lotz et al. 2014). It has been re-
ported that despite the increase of the number of tra-
beculae and the bone volume, subchondral bone is
hypomineralized and lacks quality due to an abnormal
local bone turnover (Li et al. 2013). Moreover, synovitis
turned out to play a pivotal role in OA progression, cor-
relating with symptom severity, rate of cartilage degener-
ation and osteophytosis (Scanzello 2012). So,
morphological features of OA include phenotypic
changes in chondrocytes, progressive fibrillation of ar-
ticular cartilage, subchondral bone sclerosis, osteophyte
formation, increased remodeling of the periarticular
bone and synovial hypertrophy (Li et al. 2013). For this
reason, OA is defined a whole joint pathology (Poole
2012).
The early stage of this whole joint pathology is mainly
characterized by a catabolic, inflammatory environment
and the “chondropenia”: a loss of hyaline articular cartil-
age volume and biochemical, ultrastructural and mechan-
ical properties modifications of tissue (Aydin et al. 2007;
Speziali et al. 2015). Despite the normal gross appearance
of cartilage, an altered gene expression profile is already
present from the earliest developmental stages of disease
(Wang et al. 2009). The progressive degenerative process
in OA is caused by an unbalancing of extracellular matrix
components turnover as collagens and proteoglycans, in
combination with an enhancement of metalloproteinases
and aggrecanases (MMP13 and ADAMT-4 and 5) synthe-
sis and secretion (Speziali et al. 2015). Proteolytic enzymes
production is induced by proinflammatory citokines (IL-1,
NFk-B, TNF-1) which are responsible of the matrix deple-
tion and subsequent cartilage thickness reduction and
breakdown (Nöth et al. 2008). Furthermore, OA seems to
be associated with changes in the quantity, phenotype,
and differentiation potential of resident mesenchymal
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cells, fundamental for the injury healing process and tissue
homeostasis maintaining (Nöth et al. 2008).
The goal of the most straight forwarded surgery for AOA
should be the early phase, using a disease modifying, joint
sparing procedure with long term effects (Gomoll et al.
2012). So, the ideal treatment should control the catabolic
joint environment, reversing the degenerative progress,
repairing the osteochondral layer and sparing the native joint.
In case of osteochondral lesions and early signs of
AOA, bone marrow stimulation techniques have been
usually performed, with quite good results even at long
term follow-up (Kim et al. 2014). Nevertheless, the
fibrocartilage quality of the new restored osteochondral
layer is not desirable, and regenerative technique are
usually preferred. However, regenerative procedures has
been usually considered a contraindication in case of
articular degeneration: the few attempts to implant
chondrocytes ended in disappointing results (Filardo
et al. 2013; Lee et al. 2012).
Drawbacks of previous treatments along with the
potentiality of mesenchymal stem cells (MSCs) make a
cell based approach suitable for early AOA. MSCs are
multipotent stromal cells that can differentiate in several
cell types responding to local environmental stimuli such
as cytokines and growth factors, which are released in
response of tissue injury (Minguell et al. 2001; Murphy
et al. 2013).
Self-renewal and differentiation potentiality are not the
unique features of MSCs. MSCs are able to modulate
local microenvironment and neighbor cells by cytokines,
growth factors, colony stimulating factors and chemo-
kines secretion (Minguell et al. 2001). This paracrine
activity is responsible of anti-inflammatory effect of
MSCs (Somoza et al. 2014). MSCs produce macromole-
cules such as collagens, fibronectin, glycosaminoclycans
and proteoglycans, important for the extracellular matrix
(ECM) organization, a fibrillar network essential in de-
termining tissue architecture by providing a framework
for cell adhesion (Nöth et al. 2008).
Another features of MSCs is their immunomodulatory
capabilities and the ability of influencing both adaptive
and innate immune responses (Zhao et al. 2010).
MSCs have been considered as naturally immunoprivi-
leged cells displaying low expression levels of HLA class I,
no expression of HLA class, and no expression of costimu-
latory molecules (Zhao et al. 2010). It is well-known that
under inflammatory stimulation they can express both
HLA-I and HLA-II but it is also known that under this
condition they exert more potent immunosuppressive
actions. The regulatory effect of MSCs on immunological
cells has been widely studied demonstrating that, in vivo
and in vitro, MSCs inhibit effector T cells proliferation and
prevent dendritic cells (DCs) maturation (Spaggiari et al.
2008).
For these reasons, in the last years, MSCs were sug-
gested as a therapeutic tool for the treatment of OA.
Transplantation of bone marrow derived autologous
MSCs in patients with knee, hip or ankle OA lacked ad-
verse effects and was completely safe (Emadedin et al.
2015; Jo et al. 2014). Emadedin et al treated 6 moderate
and severe AOAs with a single injection of autologous
bone marrow derived MSCs, after a previous isolation
and expansion process: clinical scores based on pain and
functionality increased in the first six months and main-
tained a positive trend until 30 months (Emadedin et al.
2015). Even MRI showed signs of osteochondral repair
and reduction of the subchondral edema. Jo et al re-
ported similar clinical results in 18 knees with moderate
or severe OA, treated with a diagnostic arthroscopy and
MSCs injection: MRIs and second look arthroscopies
with biopsy samples after 6 months demonstrated signs
of regeneration, with good filling of the defects and hya-
line like cartilage repair (Jo et al. 2014). Moreover, Hauser
et al, reported that the direct injection of unfractionated
whole bone marrow (WBM) in conjunction with hyperos-
motic dextrose for treatment of osteoarthritic joint,
reduces pain and improves articular functionality (Hauser
& Orlofsky 2013).
In a previous paper by Buda et al, a one-step technique
using bone marrow derived cells was applied for osteo-
chondral lesions of the talus (Buda et al. 2015). The pro-
cedure employed a concentrate of autologous bone
marrow-derived stem cells harvested from the patient’s
posterior iliac crest, biological and biodegradable scaffold
(hyaluronic acid) and platelet-rich fibrin (PRF), used as a
source of growth factors (such as TGF-B1 and PDGF) to
improve the healing process. The clinical results achieved
a mean excellent Aofas score at 48 months; MRI showed
good filling of the defects with well integrated borders in
most patients (Mocart scale) and signals compatible with
hyaline like cartilage in 85 % of the patients (T2 mapping
evaluation). This technique was also compared to a similar
cluster of 40 patients treated with autologous chondro-
cytes implantation: clinical and radiological results were
comparable.
The combination of MSCs, biological scaffold and
platelet-rich concentrates is fundamental to improve chon-
drogenic differentiation and cell growth, regeneration of a
tissue qualitatively and functionally more similar to normal
cartilage, and the control of the articular environment. All
of these components generate a bioactive construct com-
pletely integrated with the joint microenvironment and
surrounding tissues (Schär et al. 2015). This technique
should be reserved to focal osteochondral defects and
concomitant mild or moderate OA, in young and active
patients willing to take on a long rehabilitation.
The principal problem related to the use of native
MSCs for transplantation is heterogeneous composition
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of cell population, including differentiated and undif-
ferentiated cells. To overcome this problem, new
strategies for inducing chondrogenic differentiation of
MSCs or methods to select a single cell type are under
investigation. Application of microRNA (miRNA) and
small molecules seem to be an answer since they are
able to regulate multiple molecular pathways and
cellular processes such as differentiation (Nöth et al.
2008).
Conclusions
Treatment of early AOA is still debated and no clear guide-
lines are currently available. Joint sparing procedures are
recommended in young patients with AOA, but the results
are not so positive and sometimes contradicting: only oste-
otomy in case of malalignment is universally accepted.
Recently, a great interest about biological procedures in
early degenerative disease has aroused. Mesenchymal stem
cells may play a crucial role in case of degeneration, due to
their immunomodulatory peculiarities and the their regen-
erative prompt: the two features may allow a whole joint
approach in case of AOA, regulating the cytokine cascade
and restoring the osteochondral tissue as well. Few sporadic
data are available about mesenchymal stem cells in degen-
erated joints, sometimes using an injective procedure and
sometimes applying the cells on a scaffold, with encour-
aging results. In osteochondral defects, few reports about
mesenchymal stem cells seeded on scaffold in non-
degenerated joints are available: signs of osteochondral
regeneration were described. It seems that the autologous
bone marrow derived MSCs transplantation may be a
promising procedure in order to modulate the degenera-
tive pathway and restore the osteochondral defects.
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